So many of my patients are still unable to pay $300 out of pocket, so access to our most socially vulnerable patients is going to continue to be an issue in 2026. Wegovy is also approved to reduce the risk of heart attack, stroke or death in adults with overweight or obesity and established heart disease
2013 Aug Nazzareno Ballatori, Suzanne M Krance, Sylvia Notenboom, Shujie Shi, Kim Tieu, Christine L Hammond
When retatrutide becomes available in 20272028 and NICE approves it, it may offer patients on surgical waiting lists a pharmacological bridge or in some cases, a definitive alternative that produces outcomes in the same range as the surgery they are waiting for
BPC 157, also known as Body Protection Compound 157, is a synthetic peptide derived from a natural protein found in gastric juices
The good news is that, with the right strategies, most side effects are mild, manageable, and often fade after the first few weeks
9 Oxford University Hospitals NHS Foundation Trust, Oxford, UK
